Objectives: The majority of children with community-acquired pneumonia (CAP) are primarily evaluated in community hospital emergency departments (EDs); however, studies on the management of pediatric CAP have largely targeted care provided in freestanding children's hospital EDs or inpatient settings. The objectives of this study were to examine whether implementation of a CAP pathway within three community hospital EDs and inpatient units improved process measures related to appropriate laboratory testing and antibiotic prescribing and to compare performance on these measures between the community hospitals and a freestanding children's hospital.
P ediatric community-acquired pneumonia (CAP) remains one of the most prevalent and costly indications for pediatric evaluation in a medical setting, with an average of 375,000 emergency department (ED) visits annually and an average cost of $8,293 per hospital encounter. [1] [2] [3] In 2011, the Infectious Disease Society of America (IDSA) published clinical practice guidelines (CPGs) to help standardize the management of pediatric CAP to improve quality and reduce unnecessary cost. 4 The implementation of clinical pathways within EDs and hospitals is an effective strategy for optimizing the adoption of CPGs, leading to reduced variation in care, reduced costs, and higher-quality care. [5] [6] [7] [8] From reducing solitary blood cultures to improving time-to-inhaled corticosteroid administration for patients with asthma, ED-targeted quality improvement (QI) interventions have improved care and decreased admissions. 9, 10 As 85% of pediatric CAP visits occur in general EDs rather than pediatric ED settings, 3 it is critical to understand whether implementation of clinical pathways in these settings leads to improved processes and outcomes of care. Clinical pathway implementation in community hospitals may prove to be beneficial in the case of pediatric CAP as adherence to the IDSA recommendations, which emphasize judicious laboratory testing and empiric narrow-spectrum antibiotic use, remains suboptimal. 11 Potential drivers for not adhering to CPG recommendations in community hospitals may include diagnostic uncertainty, clinical inertia in regard to changing practice patterns, a lack of accepted criterion standard for diagnosing CAP, few pediatric-specific protocols, and limited pediatric training among providers.
The objectives of this study were to examine whether implementation of a new CAP pathway in three community hospital EDs and inpatient units improved process measures related to: 1) laboratory testing, 2) diagnostic imaging, 3) narrow-spectrum antibiotic stewardship, and 4) macrolide stewardship. Additionally, we aimed to compare differences in performance on these diagnostic and therapeutic process measures between the community hospitals and a freestanding children's hospital with an established CAP pathway. Ultimately, the goal was to inform targets for future QI in the community hospital setting.
METHODS
Study Design, Setting, and Population Using a quasi-experimental study design, we examined relationships between implementation of a new uncomplicated CAP pathway in three community hospitals with general EDs and processes and outcomes of care. A freestanding, tertiary children's hospital with an established clinical pathway for CAP provided comparative data. The community hospitals were located within the catchment area of the tertiary children's hospital. Community hospital ED visits range from 56,000 to 95,000 visits/year with pediatric patients composing 9% to 14% of the total patient volume and are staffed by general-trained ED providers. Pediatric hospitalists are available for consultation in the ED and also staff six-to 14-bed inpatient pediatric units. Prior to implementation of the QI intervention, no standardized protocol for CAP diagnosis or management existed at any of the community hospitals. The tertiary children's hospital is a 350-bed teaching hospital with an average ED volume of 35,000 visits/ year.
Eligible children were 2 months to 18 years of age who presented to the ED with a primary or secondary diagnosis of uncomplicated CAP based on International Classification of Diseases, ninth revision (ICD-9) or tenth revision (ICD-10) codes during the study period. ICD-9 codes for uncomplicated CAP were chosen based on a previously published algorithm 12 and subsequently converted into ICD-10 codes. We excluded patients with empyema or lung abscess to restrict our sample to otherwise healthy children with uncomplicated CAP. Patients requiring intensive care admission were also excluded as none of the community hospitals have a pediatric intensive care unit (ICU). All patients requiring transfer from a community hospital to the children's hospital were excluded from all analyses due to either having complicated pneumonia or requiring ICU admissions. Patients directly admitted to the pediatric ward without an ED evaluation were also excluded from all analyses.
To adequately compare process measures between similar patient populations within community hospitals and the tertiary care children's hospital, we used the validated Pediatric Medical Complexity Algorithm (PMCA) 13 to identify and exclude patients from the children's hospital cohort who are not routinely cared for in community hospitals. We excluded all patients categorized as having a complex chronic condition. Patients classified as having noncomplex chronic conditions were individually chart reviewed for inclusion. Patients with medical conditions that are routinely cared for in community hospitals were included (e.g., asthma, eczema, diabetes), whereas patients with conditions that require transfer to a tertiary children's hospital (e.g., double-outlet right ventricle) were excluded.
QI Intervention
Based on the 2011 IDSA CPG, a clinical pathway for uncomplicated CAP was implemented at the children's hospital in 2012, with the goal of reducing unnecessary laboratory testing and broad-spectrum antibiotic use.
14 Using a combination of this clinical pathway, the IDSA guidelines, and new literature since the publication of the guidelines, the study team began development of an uncomplicated CAP pathway tailored for community hospital EDs and inpatient units in October 2015. The pathway was designed to target the ED setting, and included a clinical decision tool (CDT) as a diagnostic aid for pediatric patients presenting with respiratory distress. The CDT was intended to help providers distinguish between common respiratory conditions such as pneumonia, bronchiolitis, asthma, and croup (Data Supplement S1, available as supporting information in the online version of this paper, which is available at http://online library.wiley.com/doi/10.1111/acem.13405/full). Once the provider committed to a diagnosis of CAP, they were directed to the CAP management pathway (Data Supplement S1).
Development of the community hospital CAP pathway involved a diverse team of providers including general EM providers from the community hospitals, pediatric fellowship-trained EM providers from the children's hospital, and pediatric hospitalists from each setting. Pathway development took place from October 2015 through January 2016 with six iterations of the pathway until team members reached consensus.
A few divergences from the original IDSA guidelines were built into the pathway based on literature published since 2011. First, the pathway does not recommend obtaining blood cultures for patients presenting with uncomplicated CAP, even for those requiring admission, as several studies have demonstrated that obtaining blood cultures is unnecessary for these patients. [15] [16] [17] [18] [19] Additionally, the pathway does not recommend obtaining chest radiographs (CXR) for afebrile patients presenting to the ED with wheezing, as CXRs may not differentiate viral from bacterial etiologies in these patients. 20, 21 The study included two time periods: preintervention (January through December 2015) and postintervention (March 2016 through February 2017). Implementation of the CAP pathway occurred between January and February 2016, and included: 1) an in-person presentation and distribution of electronic copies of the pathway to EM providers at each community site, 2) display of the printed pathway in provider work areas for quick on-the-job reference, and 3) an in-person presentation of the pathway to community hospital pediatric hospitalists at site-specific staff meetings. Furthermore, an additional educational session was conducted with both EM providers and pediatric hospitalists at all three sites at the beginning of respiratory season in October 2016. Given the variations between community hospital electronic health records, the pathway was unable to be incorporated into a directive order set.
Intervention Evaluation Process Measures. Process measures related to diagnostic and therapeutic interventions were collected and summarized at monthly time intervals. Community hospital data were collected using a combination of administrative data and manual medical records abstraction using a standardized tool. Children's hospital data were collected using automated abstraction from the medical record. A 10% random sample of children's hospital medical records were manually chart reviewed using the standardized tool to ensure that automated abstraction yielded similar data to the manual medical record abstraction performed at the community hospitals (kappa statistic = 0.8).
Diagnostic measures included whether or not the following tests were ordered in the ED for each patient: 1) complete blood count (CBC), 2) blood culture, 3) acute-phase reactants (defined as C-reactive protein, erythrocyte sedimentation rate, lactate, and/or D-dimer), and 4) CXR. Therapeutic measures included narrow spectrum antibiotic stewardship and macrolide stewardship. Composite scores were calculated for laboratory testing measures, narrow-spectrum antibiotic stewardship, and macrolide stewardship. We defined each diagnostic and therapeutic process measure as a dichotomous 1/0 variable, where a score of "1" was recorded if the provider adhered to the clinical pathway recommendation, and a score of "0" was recorded if they did not (see Table 1 for scoring algorithm).
Demographics. We collected the following patient demographic characteristics from administrative data: age, sex, race/ethnicity, insurance status (public, private, self-pay, or other), and medical complexity (only for children's hospital patients using the PMCA algorithm).
Balancing Measures. We examined the relationship between CAP pathway implementation and ED and inpatient length of stay (LOS), cost, 7-day ED revisits, and 7-day inpatient readmissions as balancing measures. Cost data were initially obtained as charges and converted to costs using the 2016 Health Care Authority's Medicaid cost-to-charge ratio. 22 All costs were subsequently inflation adjusted to 2016 dollars using the medical care services component of the Consumer Price Index. 23 Data Analysis. Prior to starting data collection at each site, a random sample of charts from the blackout period was used to establish interrater reliability of the manual chart abstraction process. The abstraction process was reviewed and revised until prevalenceadjusted bias-adjusted kappa ratios were >0.8 across all raters. 24 Data were analyzed over a 26-month period starting in January 2015 through February 2017, including 12 months pre-and postintervention with a 2-month blackout period for implementation in the community sites. Using t-tests and chi-square statistics, we compared hospital and demographic characteristics, differences in individual and composite measure adherence between the pre-and postintervention periods, and differences in adherence between the postintervention period in community hospitals and the same time period in the children's hospital.
Statistical process control (SPC) charts were used to examine variation in process measures over time. SPC charts help to distinguish random variation in a CXR = chest radiograph. *A score of "1" was assigned if the provider adhered to the clinical pathway recommendation, and a score of "0" was assigned if the provider did not adhere to the clinical pathway recommendation. †Acute-phase reactants were defined as C-reactive protein, erythrocyte sedimentation rate, lactate, and/or D-dimer process from assignable or identifiable causes with special cause variation defined as: 1) 8 consecutive points above the mean line, 2) 2 of 3 points being within the top third of the upper or lower control limit, or 3) a single point outside the control limits. 25 Control limits were set at three standard deviations above and below the mean. We used P-charts, a graphical representation of attribute, classification data, in this analysis as process measures were computed as a proportion (% adherence to the measure). All charts were created using the QI Charts 2.0 add-on for Microsoft Excel. 26 We examined differences in balancing measures (LOS, cost, and 7-day ED revisits and readmissions) between the pre-and postintervention periods using multivariable regression models, adjusting for influenza season (October through March), 27 patient age, race/ethnicity, insurance type, and hospital site. We applied linear regression models for LOS, log-linear models for costs, and logistic regression models for ED revisits and readmission. LOS was analyzed in the ED setting and inpatient setting separately. We were unable to separate community hospital ED costs from inpatient costs; therefore, ED cost models included encounters where patients were discharged from the ED, and total cost models included patients who presented to the ED and required an inpatient admission. Similar LOS and cost models were used to examine differences in balancing measures between the postintervention period in community hospitals and the same time period in the children's hospital, except we removed hospital site as a covariate in these models. Statistical analyses were conducted using Stata version 12.1.
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Ethical Consideration. Study approval was obtained from the institutional review board at each hospital.
RESULTS

Demographics
Across the three community hospitals, 544 patients in the preintervention period and 321 patients in the postintervention period met inclusion criteria (Table 2) . Aside from patient sex and ED encounters, there were no significant differences in hospital or patient demographic characteristics between the preand postintervention periods. An additional 290 patients met inclusion criteria in the children's hospital during the postintervention period. Patients in the †Children's hospital value or demographic distribution is significantly different from community hospital postintervention period ( a p < 0.05, b p < 0.01, and c p < 0.001).
community hospitals were younger, less racially and ethnically diverse, and more likely to be publicly insured compared to patients receiving care in the children's hospital.
Process Measures
Process measure adherence pre-and postintervention is presented in Table 3 . Adherence was higher postintervention for all of the individual diagnostic and therapeutic measures, except inpatient macrolide stewardship. Significant differences were noted for the CBC and blood culture laboratory testing measures, as well as the ED narrow-spectrum antibiotic stewardship measures. Composite measure adherence for laboratory testing, narrow-spectrum antibiotic stewardship, and macrolide stewardship also increased postintervention, with significant differences noted for the composite laboratory testing and narrow-spectrum antibiotic stewardship measures.
In the postintervention period, adherence to both individual and composite laboratory testing measures in community hospitals increased to rates that were similar to the children's hospital (Table 3) . However, narrow-spectrum antibiotic and macrolide stewardship remained lower than the children's hospital, with significant differences noted for initial narrow-spectrum antibiotic stewardship and macrolide stewardship in the ED. We were unable to compare differences in adherence between community hospitals and the children's hospital regarding the CXR process measure due to difficulty determining eligibility using children's hospital administrative data.
Statistical process control charts demonstrated that adherence for the composite laboratory testing measure improved over time across the community hospitals, with special cause variation in March 2016 immediately after the intervention was implemented (Figure 1) . Narrow-spectrum antibiotic stewardship CXR = chest radiograph; NA = not applicable due to difficulty determining eligibility using administrative data. *Adherence to process measures are computed as the proportion of patients who received the appropriate diagnostic or therapeutic management dichotomously scored as 1 or 0, where higher numbers indicate higher quality. †Difference in adherence between the postintervention period compared to the preintervention period ( a p < 0.05, b p < 0.01, and c p < 0.001) ‡Difference in adherence between the community hospital postintervention period compared to the children's hospital ( a p < 0.05, b p < 0.01, and c p < 0.001). §Row represents composite scores, where adherence to the measure is computed as the proportion of encounters with adherence to all of the individual process measures within that category.
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trended toward improvement during the study period; however, there was no special cause variation (SPC chart not shown). Macrolide stewardship increased over time with special cause variation occurring in September 2016 (Figure 2) . SPC charts for process measures tracked in the children's hospital did not demonstrate special cause variation or trends throughout the study period.
Balancing Measures
There were no significant differences in ED LOS, inpatient LOS, ED cost, total cost, 7-day ED revisits, and 7-day inpatient readmissions between the pre-and postintervention periods (Data Supplement S2, available as supporting information in the online version of this paper, which is available at http://onlinelibra ry.wiley.com/doi/10.1111/acem.13405/full). In comparison to the children's hospital, community hospitals had significantly lower ED and total costs (Data Supplement S3, available as supporting information in the online version of this paper, which is available at http://onlinelibrary.wiley.com/doi/10.1111/acem. 13405/full). Unadjusted results were similar to adjusted results.
DISCUSSION
Implementation of an evidence-based clinical pathway for CAP management through a multisite collaboration improved process measure adherence related to appropriate laboratory testing, narrow-spectrum antibiotic stewardship, and macrolide stewardship. For the laboratory testing measures, SPC analysis demonstrated special cause variation immediately following the intervention, signifying a correlation between intervention implementation and improvement. Adherence to laboratory testing measures in community hospitals was similar to the children's hospital adherence after implementation of the intervention; however, antibiotic stewardship remained lower. Finally, LOS and cost remained stable after implementation of the intervention.
Postintervention adherence to process measures for laboratory testing and antibiotic stewardship in this study were similar to those achieved in QI intervention studies conducted in children's hospitals. 14, [29] [30] [31] [32] This study adds to this body of work by demonstrating the success of a QI intervention for CAP in primarily nonpediatric settings. This success may have been due to the inclusion of diverse perspectives in development of the pathway, allowing for consideration of practice variation among those with differing levels of pediatric experience.
Although adherence to appropriate laboratory testing in the community was similar to the children's hospital; it remained lower for narrow-spectrum antibiotic and macrolide stewardship in the ED. This may be a result of providers adhering to the adult IDSA CAP guidelines, which do not recommend routine collection of blood cultures for low-risk admitted patients, but do recommend a cephalosporin and azithromycin (and/or levofloxacin) as empiric antibiotic therapy. 33 Therefore, the differences in antibiotic recommendations between pediatric and adult CPGs highlight future targets for QI initiatives at community hospitals to improve adherence to national pediatric CPG recommendations. 11, 32 Given that specific pathway recommendations vary based on immunization status, age, and local epidemiology, electronic medical record integration of clinical pathways to directly impact provider prescribing patterns may be a crucial next step. Feedback on individual provider performance and siteaggregated data may also lead to improved adherence.
For the macrolide stewardship measure, the specialcause variation noted in September 2016 was not temporally related to the initial intervention. One possibility for this variation is that macrolide stewardship improves in the fall with the onset of viral respiratory season, which may lead to lower antibiotic prescriptions overall. This was demonstrated on the SPC chart in 2015 as well. Therefore, this trend coupled with provider reeducation in October 2016 potentially led to a sustained improvement in macrolide stewardship. This should be studied further with additional data and plan-do-study-act cycles of the intervention.
Locally, we did not see a negative impact of the intervention upon our balancing measures of LOS, revisits, readmissions, or cost at any of the three community hospitals. Current published outcome data from children's hospitals on reducing broad-spectrum antibiotic use for CAP also does not demonstrate increased rates of readmission or complicated pneumonias in patients treated with narrow-spectrum antibiotics. 34 Indeed, newest literature also brings into question the utility of empiric macrolide combination therapy, even for patients > 5 years of age. 35 While locally our data were consistent with that of freestanding children's hospitals, similar national-level data on outcomes do not exist as of yet for community hospitals, which provides an opportunity for further investigation.
LIMITATIONS
This study has several limitations. First, we used ICD-9/10 codes to identify eligible patients, which may have resulted in misclassification of CAP with asthma and bronchiolitis. [36] [37] [38] For example, the higher number of patients < 2 years of age in the community hospital cohort may represent a higher degree of misclassification with bronchiolitis compared to the children's hospital. We mitigated this bias by using an established algorithm for CAP classification; however, this did require extrapolation to ICD-10 codes. Second, as a multisite study, population differences may have impacted study findings; however, we accounted for these differences by adjusting for known population-level covariates and systematically excluding patients with complex disease to ensure that the community hospital and children's hospital populations were comparable. Third, we only examined ED revisits and readmissions to the index hospital, potentially underestimating these rates. Fourth, the shift in improvement for macrolide stewardship occurred near the end of the study period; therefore, we are limited in projecting sustained change in adherence. Next, all of the community hospitals are staffed by pediatric hospitalists affiliated with the children's hospital; therefore, these results may not be generalizable to community hospitals with different staffing models. Finally, the lower volume of patients diagnosed with CAP in the postintervention period may have been a reflection of the CDT leading to more diagnostic certainty; however, the volume of patients with croup, bronchiolitis, and asthma also declined during the study period potentially representing a less severe respiratory season.
CONCLUSIONS
This study demonstrated improvement in judicious laboratory testing, narrow-spectrum antibiotic stewardship, and macrolide stewardship through implementation of a multisite clinical pathway for uncomplicated pediatric community-acquired pneumonia in community settings. Study findings revealed that antibiotic stewardship may be an important target for future quality improvement. Further studies are needed to understand how computerized provider order entry, performance feedback, and pediatric respiratory distress diagnostic tools may improve adherence to evidence-based guidelines within community hospitals. Capitalizing on evidence-based practices and guideline implementation within community hospitals has the potential to improve outcomes for large numbers of pediatric patients as community hospitals serve as the first line of care for the majority of children.
